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Edited by Gianni CesareniAbstract Ribosomal protein S6 kinase (S6K) is a key regulator
of cell size and growth. It is regulated via phosphoinositide 3-ki-
nases (PI3K) and the mammalian target of rapamycin (mTOR)
signaling pathways. We demonstrate for the ﬁrst time that CoA
synthase associates speciﬁcally with S6K1. The association was
observed between native and transiently overexpressed proteins
in vivo, as well as by BIAcore analysis in vitro. The sites of inter-
action were mapped to the C-terminal regions of both CoA syn-
thase and S6K1. In vitro studies indicated that the interaction
does not aﬀect their enzymatic activities and that CoA synthase
is not a substrate for S6 kinase. This study uncovers a potential
link between mTor/S6K signaling pathway and energy metabo-
lism through CoA and its thioester derivatives, but its physiolog-
ical relevance should be further elucidated.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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mTOR1. Introduction
Ribosomal protein S6 kinase (S6K) is involved in signaling
pathways, which regulate cell growth, size and energy metabo-
lism. Two isoforms of S6K have been identiﬁed (S6K1 and
S6K2) [1–3]. Both kinases are activated in response to mito-
genic stimuli and nutrients via PI3-K and mTOR signaling
pathways. It is believed that conformational changes induced
by multiple S/T phosphorylations open the structure, making
both N- and C-terminal regulatory domains available for pro-
tein–protein interactions. So far, only a small number of S6K-
binding partners have been identiﬁed, including PKC, PDK1,
protein phosphatase PP2A, cytoskeletal protein neurabin and
small GTP-binding proteins Rac and Cdc42 [4–8].
Ribosomal protein S6 is the best studied physiological sub-
strate of S6Ks in vivo. In addition, the transcriptional activa-
tor CREM, elongation factor 2 kinase and the regulator of
apoptosis Bad 1 were also found to be phosphorylated by
S6K1, but the physiological relevance of these modiﬁcations
remains to be further investigated [9–11].*Corresponding author. Fax: +44 207 679 7193.
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doi:10.1016/j.febslet.2004.10.091Knockout studies in mice and ﬂies provided the evidence for
the involvement of S6K in the regulation of cell growth, size
and glucose homeostasis [12]. Moreover, the mTor/S6K path-
way has been recently implicated in energy metabolism. The
link became apparent through the study of tumor suppressor
proteins, TSC1 (hamartin) and TSC2 (tuberin), which are mu-
tated in the relatively common genetic disorder, tuberous scle-
rosis [13,14]. A recent paper by Inoki et al. [14] indicated that
TSC2 plays a key role in a pathway, which maintains cellular
energy homeostasis. Another potential link to the regulation
of energy metabolism via mTor/S6K pathway became evident
with the molecular cloning of CoA synthase, which was identi-
ﬁed as an S6K-binding partner in a yeast two-hybrid screen
[15]. Biochemical and mutational analyses of CoA synthase
indicated that it possesses 4 0-phosphopantetheine adenylyl-
transferase and dephospho-CoA kinase activities, which medi-
ate to the last two steps in CoA biosynthesis. Transient
expression studies and confocal microscopy allowed us to dem-
onstrate that CoA synthase is associated with mitochondria
[16]. In this study, we demonstrate for the ﬁrst time speciﬁc
interaction between CoA synthase and S6K1 by co-immuno-
precipitation studies in mammalian cells and by BIAcore anal-
ysis in vitro. The C-terminal regions of CoA synthase and S6Ks
mediate the interaction between both proteins. CoA synthase is
not a substrate for S6K in vitro and its activity is not aﬀected by
rapamycin or LY294002 in vivo. The physiological relevance of
the identiﬁed interaction is currently under investigation.2. Materials and methods
2.1. Cell cultures and antibodies
HEK293 and MCF7 cell lines were purchased from the American
Type Culture Collection and maintained in Dulbeccos modiﬁed Ea-
gles medium supplemented with 10% fetal calf serum and antibiotics
(Invitrogen). Anti-Myc (9E-10) monoclonal antibody was purchased
from Santa Cruz. Anti-phospho S6 (pSer 240/244) and anti-phospho
S6K (pThr 389) antibodies were from Cell Signaling. Monoclonal anti-
body to the EE-tag was a gift from Julian Downward. The production
of monoclonal and polyclonal antibodies directed against S6K1 and
CoAsy was described previously [15,17,18].
2.2. Plasmid construction and expression studies
The full-length coding sequence of CoAsy, DNCoASy and DC-
CoASy deletion mutants was ampliﬁed by PCR and cloned into
pcDNA3.1 vector (Invitrogen) in frame with the C-terminal Myc-tagation of European Biochemical Societies.
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and DC-S6K1 in frame with the N-terminal EE-tag epitope were de-
scribed previously [4]. Transient transfection of HEK293 cells was per-
formed using Polyfect (Qiagen).
2.3. Immunoprecipitation and immunoblot analysis
HEK 293 cells were starved in serum-free DMEM for 24 h and then
stimulated with 10% FBS or 1lM PMA for 1 h. Cells were washed
with ice cold phosphate-buﬀered saline and extracted with lysis buﬀer,
containing 50 mM HEPES (pH 7.5), 150 mM NaCl, 1% (v/v) Nonidet
P-40, 2 mM EDTA, 50 mM sodium ﬂuoride, 10 mM sodium pyro-
phosphate, 1 mM sodium orthovanadate and a mixture of protease
inhibitors (Roche). Cell lysates were centrifuged at 10000 · g for 30
min at 4 C, and recombinant Myc-CoAsy or EE-S6K1/2 was immu-
noprecipitated with the anti-Myc or anti-EE monoclonal antibodies
immobilized on protein A–Sepharose beads (Amersham). Immune
complexes were washed three times with lysis buﬀer and used for in vi-
tro kinase assay or immunoblot analysis. Immunoblot analysis was
performed using PVDF membrane and enhanced chemiluminescence
system, as described previously [4].
2.4. Analysis of S6 kinase and CoA synthase activities in vitro
Exponentially growing MCF-7 cells were starved in serum-free and
phenol red-free DMEM for 24 h and then stimulated with 10% FBS
for 1 h. Rapamycin (150 nM) and LY294002 (60 lM) were added to
starved cells, 30 min before stimulation. Cell lysates were prepared
as described above and the extracts immunoprecipitated with the C-
terminal anti-CoAsy antibodies. The immunoprecipitates were ana-
lyzed for S6K and CoA synthase activities, as described previously
[4,15]. Expression of EE-S6K1 and CoAsy-Myc in insect cells and
aﬃnity puriﬁcation of recombinant proteins are presented in [4,16].
2.5. Characterization of S6K1 and CoASy elution proﬁles by gel
ﬁltration
Gel ﬁltration chromatography was performed on a Superose 6 10/
300 column (Amersham) connected to an AKTA FPLC system. The
equilibration, lysis and elution buﬀer contained 25 mM Tris, pH 8.5,
200 mM NaCl and a cocktail of protease inhibitors (Roche). Five hun-
dred microgram of rat brain soluble fractions after lysis (10 min on ice)
and centrifugation (15000 · g for 30 min at 4 C) was applied on a col-
umn equilibrated with lysis buﬀer. After chromatography, eluted frac-
tions were subjected to SDS–PAGE and immunoblot analysis with
anti-S6K and anti-CoAsy antibodies. Apparent molecular weight
(mass) of eluted proteins was calculated using gel ﬁltration standard
proteins, including thyroglobulin (670 kDa), bovine gammaglobulin
(158 kDa), chicken ovalbumin (44 kDa), equine myoglobin (17
kDa), and vitamin B12 (1.35 kDa). Void volume corresponded to the
elution of Blue Dextran 2000.
2.6. Biosensor experiments
The basic operating procedures of the surface plasmon resonance
BIAcore biosensor (BIACORE AB, Uppsala) have been published
[19]. A biosensor chip (CM-5, BIACORE AB) was used to immobilize
CoASy, using the amine coupling kit (BIACORE AB). CoAsy was ap-
plied at a concentration of 7 lg/ml in 20mMacetate buﬀer, pH 4.5, until
approximately 12000 Resonance Units (RU) were obtained. A separate
surface was similarly coated with the dephospho CoAsy kinase, which
served as a control. All interactions were carried out in 20 mMHEPES,
pH 7.4, 150 mM NaCl, 3.4 mM EDTA, 0.005% Tween 20, and 4 mM
dithiothreitol. Varying concentrations of S6K in the above buﬀer (5–
500 nM) were injected over the two surfaces at a ﬂow rate of 10 ll/
min at 25 C, and the response at equilibrium was recorded. The re-
sponse from the control surface was subtracted and the data plotted
as Resonance Units (RU) vs S6K concentration. The equilibrium disso-
ciation constant KD was calculated by ﬁtting the data to the equation
R = Rmax · C/(KD + C), where R is the response at equilibrium, Rmax
the maximum response level and C the concentration of protein.3. Results
The yeast two-hybrid screen was used to isolate binding
partners towards wild type and activated forms of S6K1. Thisapproach allowed us to identify several novel S6K1 interacting
molecules. One of them was found to encode a novel protein.
It was identiﬁed in two independent yeast two-hybrid screens
with mouse embryo and HeLa cDNA libraries. In our initial
studies, we focused on molecular cloning, biochemical and
functional characterization of this protein. We found that this
protein mediates the last two steps in CoA biosynthesis via 4 0-
phosphopantetheine adenylyltransferase and dephospho-CoA
kinase activities and termed it CoA synthase [15]. Further-
more, we demonstrated that CoA synthase is localized on
the outer mitochondrial membrane and that its activity is
strongly activated by phospholipids [16]. Molecular cloning
and characterization of CoA synthase provided us with neces-
sary reagents required to study the speciﬁcity of interaction
with S6K1 and its functional consequence in mammalian cells.
3.1. CoAsy forms a complex with S6K1/S6K2 in mammalian
cells
To examine whether CoA synthase can interact directly with
S6K1 or S6K2 in mammalian cells, we tested the association
between transiently overexpressed and endogenous proteins.
Initially, full-length CoAsy-Myc and EE-tagged S6K1 or
S6K2 were transiently coexpressed in HEK293 cells. After
starvation for 24 h, cells were stimulated with FBS or phorbol
12-myristate 13-acetate (PMA) for 1 h. Cell extracts were sub-
jected to immunoprecipitation with anti-EE antibody, the im-
mune complexes separated by SDS–PAGE and analyzed by
Western blotting with anti-Myc antibody. Fig. 1A clearly indi-
cates that CoASy-Myc protein co-immunoprecipitates with
anti-EE antibody, indicating speciﬁc interaction between
CoAsy and S6K1 or 2. It is important to note that the interac-
tion is inducible upon stimulation with serum and PMA, but
still occurs in serum-starved cells. The immunoprecipitated
band matches a 60 kDa protein, which corresponds to
CoASy-Myc in total lysates of cells transfected with CoASy
expression plasmids. No such protein band was detected in
control immunoprecipitations (Fig. 1A, lanes 1–3). Further-
more, the interaction of endogenous proteins was investigated.
For this purpose, we used MCF7 cells, since this breast cancer
cell line overexpresses both S6K1 and CoAsy at relatively high
levels [15,17]. In this study, we tested the presence of S6K
activity in anti-CoAsy immunoprecipitates. Fig. 1B shows that
S6K activity towards ribosomal protein S6 is speciﬁcally
immunoprecipitated with anti-CoASy antibodies. No kinase
activity was found to be associated with protein A–Sepharose
beads alone. Moreover, immune complexes contain kinase
activity which is induced in response to serum and is com-
pletely inhibited by indirect inhibitors of S6K, rapamycin
(mTor inhibitor) and LY294002 (PI3-K inhibitor). The sensi-
tivity to rapamycin and LY 294002 indicates that immunopre-
cipitated activity belongs to S6K but not other kinases, which
can phosphorylate S6 protein in vitro including RSK.
3.2. Mapping the interaction domains in CoAsy and S6K1
To map the S6K1 interaction domain in CoAsy, two dele-
tion mutants were constructed in pcDNA3.1 plasmid. One mu-
tant (DC CoAsy-Myc) lacks the C-terminally localized
dephospho-CoA kinase domain. In the second mutant (DN
CoAsy-Myc), the N-terminal regulatory domain which medi-
ates the interaction with mitochondria was deleted (Fig. 2A).
Both deletion mutants were transiently expressed in Hek293
cells together with the EE-tagged version of the wild type
Fig. 1. CoA synthase interacts with S6K1 and 2 in serum starved and stimulated cells. (A) Speciﬁc interaction between transiently overexpressed
CoAsy and S6K1 and 2. HEK293 cells were transfected with pCDNA3.1/CoAsy-Myc alone, pCDNA3.1/CoAsy-Myc and pcDNA3.1/EE-S6K1 or
pCDNA3.1/CoAsy-Myc and pcDNA3.1/EE-S6K2. After transfection, cells were serum-starved for 24 h and stimulated for 60 min with 10% FCS or
1 lM PMA. The supernatants of lysed cells were immunprecipitated with anti-EE antibody and immune complexes or total cell lysates analyzed by
Western blotting with anti-Myc antibody. (B) S6K activity co-immunoprecipitates with CoAsy in MCF7 cells. Serum starved MCF-7 cells were
stimulated with 10% FBS for 1 h. Rapamycin (150 nM) and LY294002 (60 lM) were added to starved cells 30 min before stimulation. Cell lysates
were divided and subjected to immunoprecipitation with the C-terminal anti-CoAsy antibodies or protein-A beads alone. The immune complexes
and control beads were used for in vitro S6K kinase assay, using ribosomal protein S6 as a substrate. The reaction products were separated by SDS–
PAGE and analyzed by autoradiography.
Fig. 2. The interaction between CoAsy and S6K1 is mediated by their C-term regulatory domains. (A) Modular representation of CoAsy deletion
constructs, which were used in this study. The length of the fragments is marked in aa below. The Myc-tag epitope is located at the C-terminus. (B)
The C-terminal region of CoAsy associates with S6K1. HEK293 cells were transfected with pcDNA3.1/EE-S6K1 and pCDNA 3.1/DN CoASy-Myc
or pCDNA 3.1/DC CoASy-Myc plasmids. The anti-EE antibody was used for immunoprecipitation assay and the anti-Myc antibody for Western
blotting. (C) Modular representation of the N- and C-terminal deletion mutants of S6K1 used in this study. The length of the fragments is marked in
aa below. The EE-tag epitope is located at the N-terminus. (D) The C-terminal autoinhibitory domain of S6K1 interacts with CoAsy. HEK293 cells
were transfected with pCDNA3.1/DNCoASy-Myc and pcDNA3.1/EE-DC S6K1 or pcDNA3.1/EE-DN S6K1 plasmids. The anti-Myc antibody was
used for immunoprecipitation and the anti-EE antibody for Western blotting.
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antibody and the immune complexes analyzed by immunoblot-
ting with anti-Myc antibody. Fig. 2B shows that both deletion
mutants were well expressed in Hek293, but only DN CoAsy-
Myc readily co-precipitated with S6K1. No non-speciﬁc bind-
ing of exogenously expressed proteins to protein A–Sepharose
beads coupled with control IgG was observed. These results
indicate that the C-terminal region of CoAsy which possesses
dephospho-CoA kinase domain mediates the interaction with
S6K1. To determine the region in S6K1, which mediates the
binding with CoA synthase, we used DN and DC deletion mu-
tants of S6K1, schematically presented in Fig. 2C. In this
experiment, both S6K1 mutants were transiently expressed to-
gether with the DN CoAsy-Myc, as it binds more eﬃciently to
S6K1 than the full-length CoAsy. Transiently expressed DN
CoAsy-Myc was immunoprecipitated with anti-Myc antibody
followed by Western blot analysis with anti-EE antibody. As
shown in Fig. 2D, the interaction is observed between DN
CoAsy-Myc and DN S6K-EE, but not with DC S6K-EE,
indicating the necessity of the C-terminus of S6K1 for the
interaction with CoASy. We also detected the binding of the
full-length CoAsy-Myc to DN S6K-EE, but it was less eﬃcient0
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Fig. 3. BIAcore analysis of CoAsy and S6K 1 interaction. Speciﬁc
binding of S6K1 to immobilized CoAsy measured by a surface
plasmon resonance biosensor (BIACORE). The estimated equilibrium
dissociation constant (KD) of the interaction between CoASy and S6K
is 184 nM.
Fig. 4. Gel ﬁltration analysis of CoAsy and S6K1 elution proﬁles. CoAsy
hundred microgram of rat brain soluble fractions were separated by gel ﬁltrat
separated by SDS–PAGE and analyzed by immunoblotting with the anti-S6
eluted proteins was calculated using gel ﬁltration standard proteins (thyroglo
44 kDa; equine myoglobin, 17 kDa; and vitamin B12, 1.35 kDa). Void volum(data not shown). Taken together, these data indicate that the
interaction between CoA synthase and S6K1 is mediated by
their C-terminal regions, containing dephospho-CoA kinase
domain and the regulatory autoinhibitory region, respectively.3.3. Real-time analysis of interaction between the S6K and
CoASy
A surface plasmon resonance biosensor (BIACORE) was
used to monitor the speciﬁcity and the aﬃnity of the interac-
tion between recombinant S6K1 and CoASy puriﬁed from in-
sect cells. CoAsy-His and dephospho CoAsy kinase (negative
control) were immobilized to a sensorchip. Various concentra-
tions of recombinant EE-S6K were applied to the chip and the
formation of speciﬁc protein–protein complexes was moni-
tored, as described in Materials and Methods. The analysis
of the sensorgrams clearly demonstrated that S6K speciﬁcally
interacts with immobilized CoASy (Fig. 3). No speciﬁc binding
was observed when BSA was applied to the chip (data not
shown). Both BSA and S6K displayed negligible binding to
the control surface (data not shown). The analysis allowed
us to determine the equilibrium dissociation constant (KD) of
the interaction between CoASy and S6K, which was found
to be in the range of 180 nM. This study provides further evi-
dence of the speciﬁc interaction between S6K and CoA syn-
thase and indicates that it has a relatively high aﬃnity in vitro.3.4. S6K and CoASy are co-fractionates in the same high
molecular weight complexes
Cellular extracts from rat brain were separated by gel ﬁltra-
tion chromatography using Superdex 6 column. The individual
fractions were analyzed by Western blotting for the presence of
CoASy and S6K1. As shown in Fig. 4, CoASy is eluted in two
separate peaks: (a) the lower molecular range peak of 60–150
kDa, representing possibly uncomplexed CoAsy, and (b) a
high molecular mass peak in the range of 450 kDa, where
CoAsy may exist in complex with other cellular proteins. Inter-
estingly, S6K1 is mainly eluted in one high molecular mass
peak, whose proﬁle overlaps with the second peak of CoAsy
(Fig. 4). These data suggest that CoAsy and S6K1 might be
present in the same multienzyme complexes, possibly formed
on the outer mitochondrial membrane.3.5. CoAsy is not a substrate for S6K1 and its activity is not
aﬀected by inhibitors of the PI3-K and mTor pathways
The bioinformatic analyses of CoASy protein sequence re-
vealed that it does not possess sequence, corresponding to
the S6K substrate motive (RxRxxS/T). However, this motifco-fractionates with S6K1 in a high molecular mass complexes. Five
ion chromatography on a Superose 6 column. The eluted fractions was
K1 and anti-CoAsy antibodies. Apparent molecular weight (mass) of
bulin, 670 kDa; bovine gamma-globulin, 158 kDa; chicken ovalbumin,
e corresponded to the elution of Blue Dextran 2000.
Fig. 5. PPAT and dPCoAK activities are not aﬀected when cells are
treated with Rapamycin or LY294002. Overexpression of CoAsy does
not aﬀect S6K1 activity or phosphorylation of S6 protein. (A)
HEK293 cells were transfected with CoASy-Myc, serum starved and
stimulated with FBS in the presence or absence of rapamycin or
LY294002. Overexpressed CoAsy was immunoprecipitated with anti-
Myc antibody and subjected to in vitro assays measuring PPAT or
dPCoAK activities. (B) HEK293 cells were transfected with
pCDNA3.1/CoAsy-Myc or vector alone. After transfection, cells were
serum-starved for 24 h and stimulated for 60 min with 10% FCS. The
supernatants (20 lg of total protein) were analyzed by Western
blotting with anti-phospho S6 (pSer 240/244) and anti-phospho S6K
(pThr 389) antibodies.
I. Nemazanyy et al. / FEBS Letters 578 (2004) 357–362 361is not so stringent for S6K as in the case of ribosomal protein
S6. Therefore, we carried out an in vitro S6 kinase assay using
recombinant CoASy and ribosomal protein S6 as substrates.
We found no observable phosphorylation of CoA synthase,
while S6 protein was readily phosphorylated (data not shown).
In addition, the eﬀect of rapamycin and LY294002 on CoAsy
was investigated in Hek293 cells transiently transfected with
CoAsy-Myc. No signiﬁcant changes in CoAsy enzymatic activ-
ities (4 0-phosphopantetheine adenylyltransferase and dephos-
pho-CoA kinase) were found in cells treated with rapamycin
and LY294002, when compared with not treated cells (Fig.
5A). In addition, we detected no considerable changes in
S6K1 activity when CoASy was overexpressed in HEK293
cells (Fig. 5B).4. Discussion
Genetic studies in ﬂies and mice strongly indicate that S6K is
involved in the regulation of cell growth. The induction of cel-
lular biosynthetic pathways in response to mitogenic stimuli
and nutrients is a prerequisite for the accumulation of cellular
mass. S6K has been implicated in the augmentation of ribo-
somal biogenesis and the initiation of protein synthesis. These
events are at least partly regulated via the phosphorylation ofribosomal protein S6 or yet unidentiﬁed substrate/s of S6K.
This report uncovers a novel link between mTor/S6K pathway
and another biosynthetic event in the cell, involving CoA syn-
thase. The biochemistry of CoA biosynthesis was uncovered
several decades ago, but molecular cloning of its key enzymes
including CoA synthase has been only accomplished in the last
few years. It is well known that CoA and its derivatives, Ace-
tyl-CoA and Acyl-CoA, are key players in numerous biosyn-
thetic pathways, especially energy metabolism. Therefore,
their levels and the ratio in cellular compartments are tightly
controlled by known metabolic regulators, such as insulin, glu-
cose, fatty acids and pyruvate, glucagon and glucocorticoids.
Disregulation in CoA homeostasis has been observed in sev-
eral pathological conditions, such as diabetes, Reye syndrome
and cancer. So far, very little is known about the regulation of
CoA synthase, which controls a rate-limiting step of CoA bio-
synthesis.
In this study, we present evidence for the speciﬁc interac-
tion between CoA synthase and S6K1, employing co-immu-
noprecipitation of exogenously expressed and native
proteins, BIAcore analysis and co-fractionation by gel ﬁltra-
tion. It is important to note that only relatively small
amount (less than 5%) of transiently overexpressed or endog-
enous S6K and CoAsy is present in the same complexes.
Analysis of deletion mutants indicated that the S6K1/CoAsy
interaction is mediated by their C-terminal regions. Interest-
ingly, the DN CoAsy mutant binds S6K1 much more eﬃ-
ciently than the full-length protein, indicating a possible
interaction between the N- and C-terminal domains or the
existence of conformational constrains which could be re-
leased by signaling events. We have reported earlier that
CoAsy is localized on the outer mitochondrial membrane
[15], while S6K1 is mainly present in the cytoplasm and nu-
cleus [4]. Detailed analysis of subcellular fractions and elec-
tron microscopy indicated that a small fraction of S6K1
and mTor is also present on mitochondria [10,20]. Taking
this into account, we can speculate that membrane-associated
CoAsy may form a binding platform for the formation of a
multi-enzyme complex, which may include S6K, mTor and
other signaling molecules.
We have recently found that both enzymatic activities of
CoA synthase are strongly activated by phospholipids [15]
and that the lipid-binding domain is localized in the C-termi-
nal region [A. Zhyvoloup, unpublished observation]. There-
fore, the interaction between S6K and CoAsy involving their
C-terminal domains may modulate lipid-induced activation
of CoA synthase. As expected from the bioinformatic analysis,
CoAsy was not found to be a substrate for S6K in vitro. So
far, we have not been also successful in ﬁnding the physiolog-
ical relevance of S6K/CoA synthase interaction. The activity
of CoA synthase was not meaningfully aﬀected by the addition
of recombinant S6K in vitro or by treating cells with rapamy-
cin and LY294002. However, we used in this study polyclonal
antibodies which have an inhibitory eﬀect on CoAsy enzy-
matic activities. We are currently making monoclonal antibod-
ies towards CoAsy and are in the process of developing an
NMR-based assay for measuring the level of CoA and its
derivatives in total cell lysates or cellular organelles. We hope
that new antibodies and a CoA detection assay might allow us
to elucidate the physiological signiﬁcance of an established
link between mTor/S6K pathway and CoA biosynthetic
machinery.
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